Oxford Nanopore Technologies PLC
LSE:ONT

Watchlist Manager
Oxford Nanopore Technologies PLC Logo
Oxford Nanopore Technologies PLC
LSE:ONT
Watchlist
Price: 128.8 GBX 4.89% Market Closed
Market Cap: 1.2B GBX
Have any thoughts about
Oxford Nanopore Technologies PLC?
Write Note

Oxford Nanopore Technologies PLC
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Oxford Nanopore Technologies PLC
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Oxford Nanopore Technologies PLC
LSE:ONT
Total Equity
ÂŁ643.9m
CAGR 3-Years
51%
CAGR 5-Years
35%
CAGR 10-Years
N/A
Diaceutics PLC
LSE:DXRX
Total Equity
ÂŁ31.4m
CAGR 3-Years
-8%
CAGR 5-Years
64%
CAGR 10-Years
N/A
G
Genedrive PLC
LSE:GDR
Total Equity
ÂŁ1.5m
CAGR 3-Years
-34%
CAGR 5-Years
N/A
CAGR 10-Years
-18%
Ergomed PLC
LSE:ERGO
Total Equity
ÂŁ90.9m
CAGR 3-Years
28%
CAGR 5-Years
22%
CAGR 10-Years
N/A
C4X Discovery Holdings PLC
LSE:C4XD
Total Equity
ÂŁ24.6m
CAGR 3-Years
9%
CAGR 5-Years
14%
CAGR 10-Years
N/A
hVIVO PLC
LSE:HVO
Total Equity
ÂŁ38.5m
CAGR 3-Years
21%
CAGR 5-Years
38%
CAGR 10-Years
39%
No Stocks Found

Oxford Nanopore Technologies PLC
Glance View

Market Cap
1.1B GBX
Industry
Life Sciences Tools & Services

Oxford Nanopore Technologies Plc develops proprietary technology platform for the electronic analysis of single molecules. The firm develops sensing technology that uses nanopores - nano-scale holes embedded in electronics, to perform molecular analyses. Its products sequence deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Its product includes a sensing platform, which is used for the analysis of various types of molecules, such as proteins. The firm's platform is used by scientific researchers to answer questions about the biology of people, plants, animals, pathogens and environments. The company is also used in applied settings, such as clinical diagnostics, epidemiology and food safety. Its areas of research include microbiology, microbiome, environmental, plant, animal, infectious disease, human genomics, clinical research, cancer, transcriptome and populations genomics. The firm's other products include MinION, GridION, PromethION, VolTRAX, Flongle Flow Cells, PromethION Flow Cells, and MinION and Gridion Flow Cells.

ONT Intrinsic Value
181.2 GBX
Undervaluation 29%
Intrinsic Value
Price

See Also

What is Oxford Nanopore Technologies PLC's Total Equity?
Total Equity
643.9m GBP

Based on the financial report for Dec 31, 2023, Oxford Nanopore Technologies PLC's Total Equity amounts to 643.9m GBP.

What is Oxford Nanopore Technologies PLC's Total Equity growth rate?
Total Equity CAGR 5Y
35%

Over the last year, the Total Equity growth was -7%. The average annual Total Equity growth rates for Oxford Nanopore Technologies PLC have been 51% over the past three years , 35% over the past five years .

Back to Top